Teva Pharmaceutical Industries Cash Flow Statement (2009-2026) | TEVA

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
0.21B0.31B-0.15B-0.97B-0.28B0.06B-1.33B-0.25B-0.91B0.08B0.47B0.52B-0.88B-0.39B-0.28B0.22B0.28B0.43B0.47B0.37B
Depreciation and Depletion (Quarter)
0.04B0.04B
Share-based Compensation (Quarter)
0.03B0.03B0.03B0.02B0.04B0.03B0.04B0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.04B0.03B0.05B0.04B
Deferred Taxes (Quarter)
0.02B0.01B-0.13B-0.17B-1.08B0.04B0.15B-0.11B-0.04B-0.20B0.03B-0.19B-0.42B-0.05B0.03B0.03B-0.21B0.11B-0.59B-0.02B
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)
-0.00B0.50B0.00B0.00B-0.00B0.00B0.00B0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Asset Writedowns and Impairment (Quarter)
0.23B0.05B0.18B0.17B0.81B0.03B1.45B0.19B0.77B0.05B0.07B0.68B
Cash from Restructuring (Quarter)
Non-cash Items (Quarter)
Change in Working Capital (Quarter)
-0.70B-0.62B
Cash from Operations (Quarter)
0.22B0.53B0.46B-0.05B0.12B0.54B0.97B-0.14B0.32B0.01B1.18B-0.12B0.10B0.69B0.57B-0.10B0.23B0.37B1.16B-0.04B
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
0.40B0.60B0.28B
Amortizatization of Intangibles (Quarter)
Depreciation & Amortization (CF) (Quarter)
0.30B0.33B0.32B0.32B0.36B0.32B0.31B0.30B0.30B0.28B0.27B0.27B0.26B0.26B0.27B0.24B0.25B0.25B0.26B0.24B
Change in Working Capital
Change in Receivables (Quarter)
-0.26B-0.08B
Change in Inventory (Quarter)
-0.12B-0.09B
Change in Accured Expenses (Quarter)
-0.04B-0.14B
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
0.60B0.20B-1.86B0.03B-0.35B-0.09B0.18B0.35B-0.21B0.23B-0.29B0.00B0.59B0.00B-0.04B-0.01B0.10B0.56B-1.51B-0.30B
Investing Activities
Capital Expenditures (Quarter)
0.11B0.15B0.15B0.16B0.13B0.12B0.14B0.14B0.12B0.15B0.12B0.12B0.10B0.15B0.13B0.13B0.10B0.14B0.14B0.17B
Acquisitions (Quarter)
0.01B0.01B
Divestments (Quarter)
0.12B0.01B0.04B0.03B0.02B0.00B0.02B0.00B0.06B0.01B0.00B0.04B0.00B0.02B0.01B0.01B0.04B
Change in Acquisitions & Divestments (Quarter)
0.11B0.02B0.00B0.00B0.04B0.04B
Cash from Investing Activities (Quarter)
0.48B0.29B0.25B0.16B0.18B0.15B0.17B0.18B0.30B0.18B0.30B0.14B0.18B0.27B0.20B0.20B0.24B0.14B0.17B0.23B
Financing Activities
Other financing activities (Quarter)
-0.00B-0.00B-0.00B0.00B-0.04B-0.07B-0.00B-0.01B-0.06B-0.08B-0.08B-0.01B-0.01B0.01B0.00B0.00B-0.00B0.04B0.04B
Cash from Financing Activities (Quarter)
-0.00B-1.18B-0.50B0.00B-0.34B-0.44B-0.71B-0.71B-0.06B-0.58B-0.58B-0.15B-0.97B-0.67B-1.74B0.01B-0.45B0.04B0.01B
Dividend Payments
Dividends Paid - Common (Quarter)
Additional items
Exchange Rate Effect (Quarter)
-0.01B-0.03B-0.05B-0.06B-0.12B-0.08B0.15B0.01B-0.08B-0.03B0.07B-0.10B-0.05B0.10B-0.12B0.04B-0.01B-0.01B-0.01B-0.02B
Change in Cash (Quarter)
0.69B-0.39B0.15B0.05B-0.16B0.17B0.58B-0.66B0.49B-0.42B0.98B-0.24B-0.73B1.06B-0.02B-1.60B0.46B0.04B1.35B0.18B
Free Cash Flow (Quarter)
0.10B0.38B0.30B-0.21B-0.00B0.42B0.83B-0.28B0.20B-0.14B1.06B-0.25B0.01B0.55B0.45B-0.23B0.13B0.23B1.02B-0.21B
Net Cash Flow (Quarter)
0.70B-0.36B0.20B0.11B-0.04B0.25B0.43B-0.67B0.57B-0.39B0.91B-0.13B-0.69B0.96B0.10B-1.65B0.47B0.05B1.36B0.20B